Did you know there’s even more we can do to promote your episode? Find out more…
Julian Casciano, President & CEO at eMAX Health talks about how his personal experience shaped his path into healthcare.
Our host Raman Sehgal talks about the internal challenges and biggest opportunities CDMO CEOs face in 2026.
Pep Gubau, CEOm, CTO & Co-Founder at Aizon talks about the role that AI plays in the pharma manufacturing industry.
Our host Raman Sehgal talks about the big headwinds for the pharmaceutical and biotechnology space for 2026.
Our host discusses with three senior leaders on their insights from The JPM’s Annual Healthcare Conference 2026.
Our host Raman Sehgal summarises predictions from CDMO C-suite leaders for the pharmaceutical and biotechnology space for 2026.
Selin Kurnaz, Co-Founder & CEO of Massive Bio talks about the role of AI in drug development and her entrepreneurial journey.
Jim Gale, Founding Partner & Managing Director at Signet Healthcare Partners discusses the importance and impact of private equity.
Here is our host, Raman Sehgal’s top 5 Molecule to Market episodes of 2025.
Dr Thomas Dobmeyer, ekwithree talks about his medical career, his experience in niche regulatory affairs and investment.
